Ottawa, Dec. 09, 2025 (GLOBE NEWSWIRE) -- The global optic nerve atrophy treatment market size is calculated at USD 2.75 billion in 2025 and is expected to reach around USD 5.87 billion by 2034, ...

The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...

Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...

Glaucoma often described as the “silent thief of sight” affects millions in India with most cases remaining undiagnosed.

Jan 8 (Reuters) - Biogen Idec Inc said on Thursday a mid-stage study of a new treatment for acute optic neuritis, an inflammation of the optic nerve that can lead to complete or partial loss of vision ...

Increase in prevalence of optic nerve disorder treatment, growth in geriatric population and increase in technological advancement drive the growth of the global optic nerve disorder treatment market.

Pituitary tumors can compress the optic nerve, leading to visual symptoms. Pituitary tumors are mostly benign (noncancerous), but due to their location, they can have significant effects on ...

Glaucoma is when the optic nerve in the eye becomes damaged. The different stages of narrow angle glaucoma relate to the extent of the damage to the optic nerve and the level of pressure in the eye.

Traumatic injury to the brain, spinal cord and optic nerve in the central nervous system (CNS) are the leading cause of disability and the second leading cause of death worldwide. CNS injuries often ...

As the number of children born with a vision-impairing condition known as optic nerve hypoplasia (ONH) increases, scientists with the Fralin Biomedical Research Institute at VTC are investigating ...

Please provide your email address to receive an email when new articles are posted on . Neuro-ophthalmologists have a lighthearted attitude about the perception of their specialty because, for many ...